ODN 21595, a guanine-modified inhibitor targeting TLR7 and TLR9, effectively inhibits the release of IFN-alpha and IL-6 without exhibiting cytotoxicity. It also reduces the expression of CD86 and HLA-DR, showcasing potential for systemic lupus erythematosus
CAS Number:
[1964506-28-2]
* VAT and and shipping costs not included. Errors and price changes excepted
